4.7 Article

OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's Disease

Marcia Maria de Souza et al.

Summary: Alzheimer's disease is a chronic neurodegenerative disease and the most common form of dementia, especially in the elderly. Recent studies indicate that the overexpression of the DYRK1A gene may play a significant role in developmental brain disorders and early onset neurodegeneration, neuronal loss and dementia. Inhibiting DYRK1A may serve as a potential treatment strategy for age-associated neurodegeneration, including Alzheimer-type pathology.

CURRENT MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

DYRK1A inhibitors for disease therapy: Current status and perspectives

Tong Liu et al.

Summary: DYRK1A, a conserved protein kinase, plays essential roles in various biological processes and is associated with Down syndrome, neurodegenerative diseases, cancer, and diabetes. The development of DYRK1A inhibitors has seen a rapid increase in recent years, providing new directions for future therapeutic research.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

KEGG mapping tools for uncovering hidden features in biological data

Minoru Kanehisa et al.

Summary: KEGG relies on human intelligence to develop biological system models through manually creating pathway maps. These models can be used in biological big data analysis to uncover systemic functions in an organism's genome.

PROTEIN SCIENCE (2022)

Article Oncology

UALCAN: An update to the integrated cancer data analysis platform

Darshan Shimoga Chandrashekar et al.

Summary: UALCAN is a web portal for exploring, analyzing, and visualizing cancer genomic, transcriptomic, and proteomic data, providing researchers with valuable insights into gene, protein, and pathway alterations in cancer, as well as evaluating patient survival data.

NEOPLASIA (2022)

Review Pharmacology & Pharmacy

Target-based anticancer indole derivatives and insight into structure-activity relationship: A mechanistic review update (2018-2021)

Ashima Dhiman et al.

Summary: Cancer, the second leading cause of death after heart disease, is characterized by the uncontrolled growth of cells. Targeting specific genes and proteins involved in the growth and survival of cancer cells has become a top priority in global research. Indole moiety, a combination of aromatic-heterocyclic compounds, has emerged as a promising scaffold for the development of anticancer drugs due to its bioavailability, unique chemical properties, and significant pharmacological behaviors. Recent advances in the medicinal chemistry of indole derivatives, including the synthesis of potential anticancer compounds and their mechanism of action, are discussed in this review.

ACTA PHARMACEUTICA SINICA B (2022)

Article Pharmacology & Pharmacy

SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells

Alan Alfano et al.

Summary: Tubulin is a vital component of the cytoskeleton and plays crucial roles in cellular signaling, maintenance, and division. Increased expression of TUBB3, a type of beta-tubulin primarily found in neural cells, is associated with taxane resistance and poor prognosis. Here, we discovered that TUBB3 is phosphorylated at Tyrosine 340 (Y340) by c-Src in prostate cancer cells. Phosphorylation at Y340 regulates TUBB3 protein stability and subcellular localization. Inhibition of SRC kinase activity affects spindle stability in mitotic cells due to the lack of TUBB3 Y340 phosphorylation. Understanding the posttranslational regulation of TUBB3 could serve as potential biomarkers for disease recurrence and treatment failure.

PHARMACEUTICS (2022)

Review Cell Biology

βIII-Tubulin Gene Regulation in Health and Disease

Alastair M. P. Duly et al.

Summary: Microtubule proteins, including beta III-tubulin encoded by the TUBB3 gene, play key roles in cellular processes, and dysregulated expression of these proteins is often observed in cancer. Understanding the regulation of TUBB3 expression in normal and cancerous tissues is important for unraveling its biological function and developing new therapeutic approaches.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Oxidative Stress-Induced Growth Inhibitor (OSGIN1), a Target of X-Box-Binding Protein 1, Protects Palmitic Acid-Induced Vascular Lipotoxicity through Maintaining Autophagy

Chong-Sun Khoi et al.

Summary: This study investigated the mechanism of vascular dysfunction induced by palmitic acid, and revealed the crucial roles of XBP1s and OSGIN1 in maintaining endothelial cell migration and regulating autophagy.

BIOMEDICINES (2022)

Review Biochemistry & Molecular Biology

An overview on the exploring the interaction of inorganic nanoparticles with microtubules for the advancement of cancer therapeutics

Weidong Zhang et al.

Summary: This review explores the potential strategy of targeting microtubules with inorganic nanoparticles as a means of combating cancer cells. It discusses the structure and interactions of microtubules with stabilizing and destabilizing agents, as well as the interaction between nanoparticles and microtubules. The review also highlights the challenges and future perspectives in the field.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Review Medicine, Research & Experimental

Development of novel derivatives of stilbene and macrocyclic compounds as potent of anti-microtubule factors

Filip Borys et al.

Summary: This review provides a brief overview of new compounds targeting the dynamic of microtubule-tubulin polymerization/depolymerization. It is divided into three parts focusing on derivatives of stilbene, photoswitchable inhibitors, and macrocyclic compounds as tubulin inhibitors. The authors primarily highlight reports from the past five years and the latest strategies in this field.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Biochemistry & Molecular Biology

βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies

Arun Kanakkanthara et al.

Summary: Understanding the regulation of beta III-tubulin expression and its functions in different cancers is crucial for assessing its prognostic value and developing therapeutic strategies. Targeting tumors overexpressing beta III-tubulin with emerging therapeutic strategies is a key focus of current research.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Microtubule-Based Mitochondrial Dynamics as a Valuable Therapeutic Target in Cancer

Rosa Vona et al.

Summary: Mitochondria are constantly rearranging dynamic networks that play key roles in cellular functions like metabolism regulation, energy production, calcium homeostasis, reactive oxygen species production, and programmed cell death. Their dynamics, including fusion, fragmentation, trafficking, biogenesis, and mitophagy, are actively involved in tumorigenesis and metabolic plasticity, contributing to tumor progression. Understanding the molecular mechanisms regulating mitochondrial dynamics can potentially lead to new molecular targets in cancer therapy.

CANCERS (2021)

Review Oncology

Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring

Damien Reita et al.

Summary: Non-small cell lung cancer (NSCLC) is the most common cancer in the world. Activating EGFR gene mutations are predictive for the efficacy of EGFR tyrosine kinase inhibitors (TKIs). Acquired resistance is a challenge, leading to the search for novel biomarkers and drug targets that vary among different generations/lines of EGFR TKIs.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview

Mattias F. Lindberg et al.

Summary: DYRK and CLK kinases are involved in various cellular functions and their abnormal expression/activity are linked to multiple neurological diseases, cancers, and other conditions. Research on the regulation of these kinases and the development of inhibitors is crucial for the treatment of related diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Health Care Sciences & Services

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Andras Lanczky et al.

Summary: The web-based tool introduced in this study enables univariate and multivariate Cox proportional hazards survival analysis using data from various genomic studies, filling a significant gap in the field where no commonly used spreadsheet software or web server is available for this purpose.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Article Biochemistry & Molecular Biology

Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC

Jian Huang et al.

ONCOGENE (2020)

Review Cell Biology

The tubulin code and its role in controlling microtubule properties and functions

Carsten Janke et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Cell Biology

Microtubule-targeting agents and their impact on cancer treatment

Vladimir Cermak et al.

EUROPEAN JOURNAL OF CELL BIOLOGY (2020)

Review Oncology

The design and development of covalent protein-protein interaction inhibitors for cancer treatment

Sha-Sha Cheng et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Biochemical Research Methods

The HDOCK server for integrated protein-protein docking

Yumeng Yan et al.

NATURE PROTOCOLS (2020)

Article Medicine, Research & Experimental

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors

Tan-Min Chin et al.

THERANOSTICS (2020)

Review Pharmacology & Pharmacy

Oxidative Stress and Cancer

James E. Klaunig

CURRENT PHARMACEUTICAL DESIGN (2018)

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

Review Chemistry, Medicinal

Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents

Anjana Devi Tangutur et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)

Review Genetics & Heredity

Class III β-tubulin in normal and cancer tissues

Marisa Mariani et al.

Article Multidisciplinary Sciences

Interaction of OKL38 and p53 in Regulating Mitochondrial Structure and Function

Jing Hu et al.

PLOS ONE (2012)

Review Medicine, General & Internal

Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship

Julian R. Molina et al.

MAYO CLINIC PROCEEDINGS (2008)

Article Cell Biology

Microtubule regulation in mitosis: Tubulin phosphorylation by the cyclin-dependent kinase Cdk1

A Fourest-Lieuvin et al.

MOLECULAR BIOLOGY OF THE CELL (2006)

Article Biochemistry & Molecular Biology

Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis

CK Ong et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Selective p38 activation in human non-small cell lung cancer

AK Greenberg et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)

Article Multidisciplinary Sciences

Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics

A Gonçalves et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)